home / stock / atrs / atrs quote
$4.47 Last:
-0.22% Change Percent:
$4.44 Open:
$4.47 Previous Close:
$4.51 High:
$4.4 Low:
1,596,308 Volume:
02/25/2021 04:55:17 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-02-25 | 4.44 | 4.47 | 4.51 | 4.4 | 1,596,308 |
2021-02-24 | 4.47 | 4.48 | 4.56 | 4.44 | 1,340,102 |
2021-02-23 | 4.74 | 4.44 | 4.755 | 4.375 | 2,747,113 |
2021-02-22 | 4.77 | 4.78 | 4.81 | 4.7 | 1,429,606 |
2021-02-19 | 4.88 | 4.83 | 4.92 | 4.77 | 1,454,420 |
2021-02-18 | 4.72 | 4.85 | 5.07 | 4.63 | 4,497,996 |
2021-02-17 | 4.52 | 4.73 | 4.76 | 4.52 | 1,252,164 |
2021-02-16 | 4.55 | 4.56 | 4.62 | 4.48 | 1,204,477 |
2021-02-15 | 4.61 | 4.53 | 4.63 | 4.5 | 1,284,711 |
2021-02-12 | 4.61 | 4.53 | 4.63 | 4.5 | 1,277,446 |
2021-02-11 | 4.69 | 4.64 | 4.7 | 4.56 | 1,023,289 |
2021-02-10 | 4.75 | 4.69 | 4.76 | 4.6 | 937,020 |
2021-02-09 | 4.75 | 4.71 | 4.75 | 4.66 | 944,742 |
2021-02-08 | 4.74 | 4.71 | 4.77 | 4.67 | 1,045,102 |
2021-02-05 | 4.6 | 4.68 | 4.71 | 4.6 | 1,252,325 |
2021-02-04 | 4.5 | 4.57 | 4.5999 | 4.46 | 1,067,937 |
2021-02-03 | 4.5 | 4.46 | 4.59 | 4.45 | 684,515 |
2021-02-02 | 4.41 | 4.52 | 4.53 | 4.3701 | 1,487,004 |
2021-02-01 | 4.43 | 4.34 | 4.43 | 4.24 | 919,868 |
2021-01-29 | 4.4 | 4.38 | 4.54 | 4.31 | 1,208,649 |
News, Short Squeeze, Breakout and More Instantly...
EWING, N.J., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer, is scheduled to present and host investor meetings at the Raymo...
EWING, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced it will release its fourth quarter and full-year 2020 financial and operating results on Tuesday, March 2, 2021, before the ...
EWING, N.J., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer, is scheduled to participate and host investor meetings at the S...